Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | eLife
Cureus | A Rare Case of Dose-Dependent Losartan-Induced Angioedema | Article
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology
A practical guide to antiproteinuric drugs in dogs
FDA Advise-ERR: Concomitant use of Entresto and ACE inhibitors Can Lead to Serious Outcomes | Institute For Safe Medication Practices
Comparison of the actions of ACE inhibitors and ARBs - UpToDate
Molecules | Free Full-Text | From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
Choice of drug therapy in primary (essential) hypertension - UpToDate
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients - Zhao - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
ACEIs and ARBs and Their Correlation with COVID-19: A Review | IDR
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
Figure 1 | ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | SpringerLink
Cureus | Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study | Article
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Aug 4, 2014: How does naloxone work to reverse the effects of ACE inhibitor toxicity? | Tennessee Poison Center | FREE 24/7 Poison Help Hotline 800.222.1222
